1. Home
  2. KVHI vs UNCY Comparison

KVHI vs UNCY Comparison

Compare KVHI & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$6.00

Market Cap

110.2M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.24

Market Cap

121.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVHI
UNCY
Founded
1978
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.2M
121.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
KVHI
UNCY
Price
$6.00
$6.24
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$44.50
AVG Volume (30 Days)
53.9K
428.0K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$107,407,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.15
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.69
$3.71
52 Week High
$6.41
$11.00

Technical Indicators

Market Signals
Indicator
KVHI
UNCY
Relative Strength Index (RSI) 55.47 63.99
Support Level $5.89 $5.77
Resistance Level $6.10 $6.70
Average True Range (ATR) 0.26 0.43
MACD 0.01 0.05
Stochastic Oscillator 82.83 71.78

Price Performance

Historical Comparison
KVHI
UNCY

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: